Endothelin-induced contraction and mediator release in human bronchus

Area of Science:

• Pharmacology
• Respiratory Medicine
• Physiology

Background:

• Endothelin-1 (ET-1) is a potent vasoconstrictor peptide.
• Its role in human airway smooth muscle contraction is not fully understood.
• Investigating ET-1's mechanisms is crucial for understanding airway diseases.

Purpose of the Study:

• To determine the role of acetylcholine and autacoids in ET-1-induced human bronchus contraction.
• To examine the effects of various receptor antagonists on ET-1-induced contraction.
• To assess ET-1's ability to stimulate the release of histamine, leukotrienes, and prostanoids.

Main Methods:

• Human bronchus tissue was used to study ET-1-induced contraction.
• Concentration-response curves were generated in the presence of various receptor antagonists.
• Levels of released mediators (histamine, leukotrienes, prostanoids) were measured after ET-1 stimulation.

Main Results:

• ET-1 was a potent contractile agonist in human bronchus, similar to leukotriene D4 (LTD4).
• Receptor antagonists for muscarinic, PAF, histamine, and leukotriene receptors did not inhibit ET-1-induced contraction.
• ET-1 stimulated the release of several prostanoids, notably prostaglandin D2, but not histamine or leukotrienes.

Conclusions:

• ET-1 elicits contraction of human isolated bronchus predominantly via a direct mechanism.
• The release of acetylcholine, leukotrienes, histamine, or platelet-activating factor (PAF) is not significantly involved.
• While ET-1 increases prostanoid release, this effect does not significantly modulate smooth muscle contraction.